Author/Authors :
Öncül, Ayşegül Mine Tüzüner Ankara Üniversitesi - Diş Hekimliği Fakültesi - Ağız, Diş, Çene Hastalıkları ve Cerrahisi A D, Turkey , Şahin, Sıla Ankara Üniversitesi - Diş Hekimliği Fakültesi - Ağız, Diş, Çene Hastalıkları ve Cerrahisi A D, Turkey , Görür, Durmuş İlker Ankara Üniversitesi - Diş Hekimliği Fakültesi - Ağız, Diş, Çene Hastalıkları ve Cerrahisi A D, Turkey , Öztürk, Adnan Ankara Üniversitesi - Diş Hekimliği Fakültesi - Ağız, Diş, Çene Hastalıkları ve Cerrahisi A D, Turkey , Orhan, Kaan Yakındoğu Üniversitesi - Diş Hekimliği Fakültesi - Oral Diagnoz ve Radyoloji B D, Turkey
Abstract :
Purpose: Bisphophonates are used in the management of metastatic bone cancers and osteoporosis. Intravenous (i.v) bisphosphonate (pamidronate, zoledronate) treatment causes the osteonecrosis of the jaws. In this case report, treatment of a referred patient, is presented. Case Report: A 51 years old female patient referred to our department with asymptomatic ostonecrosis in her left maxilla as a consequence of long term i.v. bisphosphonates consumption. The treatment protocol included debridement, sequestrectomy and hyperbaric oxygen therapy. The patient has followed up periodically. Conclusion: Occurrence of bisphosphonate induced osteonecrosis became frequent by the increase of i.v. biphosphonate usage. Therefore, the patients who will be treated by bisphosphonates must consult to a dentist and all dental treatments must be completed before the beginning of the therapy. By this way, the complications can be prevented.
